Article

Exploring epitope and functional diversity of anti-SARS-CoV2 antibodies using AI-based methods

2020-12-24

Abstract excerpt

<h4>Summary</h4> Since the beginning of the COVID19 pandemics, an unprecedented research effort has been conducted to analyze the antibody responses in patients, and many trials based on passive immunotherapy — notably monoclonal antibodies — are ongoing. Twenty-one antibodies have entered clinical trials, 6 having reached phase 2/3, phase 3 or having received emergency authorization. These represent only the tip...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e4c7e173-e3ce-56c8-8e1b-e015247458c9
DOI: 10.1101/2020.12.23.424199

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Exploring epitope and functional diversity of anti-SARS-CoV2 antibodies using AI-based methodsDOI 10.1101/2020.12.23.424199Read

AI-based antibody discovery platform identifies novel, diverse and pharmacologically active therapeutic antibodies against multiple SARS-CoV-2 strainsSemantic proximity Read

Rapid <i>in silico</i> design of antibodies targeting SARS-CoV-2 using machine learning and supercomputingSemantic proximity Read

The Patent and Literature Antibody Database (PLAbDab): an evolving reference set of functionally diverse, literature-annotated antibody sequences and structuresSemantic proximity Read

MAAD: Multidimensional Antiviral Antibody DatabaseSemantic proximity Read

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbsSemantic proximity Read

Accurate determination of epitope for antibodies with unknown 3D structures.Semantic proximity Read

OptMAVEn-2.0: De novo Design of Variable Antibody Regions against Targeted Antigen EpitopesSemantic proximity Read

Evaluation of the Ability of AlphaFold to Predict the Three-Dimensional Structures of Antibodies and EpitopesSemantic proximity Read

Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2: toward universal blueprints for vaccine designsSemantic proximity Read

De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )Semantic proximity Read

Peptide microarrays coupled to machine learning reveal individual epitopes from human antibody responses with neutralizing capabilities against SARS-CoV-2Semantic proximity Read

Epitope profiling using computational structural modelling demonstrated on coronavirus-binding antibodiesSemantic proximity Read